KESTRA MEDICAL TECHNOLOGIES, LTD.
KMTS · NASDAQ
4/30/2025 | 4/30/2024 | 4/30/2023 | 4/30/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$113,814 | -$94,120 | -$84,238 | -$34,101 |
| Dep. & Amort. | $7,968 | $11,560 | $4,855 | $420 |
| Deferred Tax | $64 | $12 | -$45 | $0 |
| Stock-Based Comp. | $24,270 | $1,488 | $1,209 | $1,863 |
| Change in WC | -$6,203 | $4,388 | $1,298 | -$19 |
| Other Non-Cash | $10,107 | $4,437 | $7,279 | $1,942 |
| Operating Cash Flow | -$77,608 | -$72,235 | -$69,642 | -$29,895 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$23,591 | -$12,514 | -$15,461 | -$336 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $283 | $285 | $0 | $2 |
| Investing Cash Flow | -$23,308 | -$12,229 | -$15,461 | -$334 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $5,877 | -$5,333 | $20,000 |
| Stock Issued | $215,789 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$1,654 | -$799 | -$671 | -$187 |
| Other Fin. Act. | $116,127 | $72,647 | $102,110 | $29,002 |
| Financing Cash Flow | $330,262 | $77,725 | $96,106 | $48,815 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $229,346 | -$6,739 | $11,003 | $18,586 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $8,583 | $15,322 | $4,319 | $6,268 |
| End Cash | $237,929 | $8,583 | $15,322 | $24,854 |
| Free Cash Flow | -$101,199 | -$84,749 | -$85,103 | -$30,231 |